This one-day symposium is designed to provide participants with relevant, reliable, up-to-date information on the clinical management of HIV-infected patients who have failed one or more antiretroviral regimens, or who have demonstrated some degree of resistance to one or more antiretroviral drugs or classes of drugs.
Enrollment Enrollment in this seminar is limited, so we suggest you enroll early. Online To enroll click here By Mail Send the completed enrollment form to: David Geffen School of Medicine at UCLA Office of Continuing Medical Education Tough Decisions Made Easier 10920 Wilshire Blvd., Suite 1060 Los Angeles, CA 90024-6512 By FAX Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624. By Phone Use your MasterCard, VISA, or Discover card. Call (310) 794-2620 Registration Fee
Program Chairs RONALD T. MITSUYASU, MD Professor of Medicine David Geffen School of Medicine at UCLA Director, Center for Clinical AIDS Research and Education Los Angeles, CA JUDITH S. CURRIER, MD Professor of Medicine David Geffen School of Medicine at UCLA Associate Director, Center for Clinical AIDS Research and Education Los Angeles, CA Symposium Faculty MARGRIT CARLSON, MD Associate Clinical Professor of Medicine David Geffen School of Medicine at UCLA Medical Director, CARE Clinic Los Angeles, CA ERIC S. DAAR, MD Professor of Medicine Chief, Division of HIV Medicine Harbor-UCLA Medical Center David Geffen School of Medicine at UCLA Los Angeles, CA MICHAEL DUBE, MD Professor of Medicine Chief, Division of HIV Medicine Harbor-UCLA Medical Center David Geffen School of Medicine at UCLA Los Angeles, CA ROY M. GULICK, MD Professor of Medicine Professor of Medicine Chief, Division of Infectious Diseases Weill Medical College of Cornell University New York, NY W. DAVID HARDY, MD Director, Division of Infectious Diseases Cedars-Sinai Medical Center Associate Professor of Medicine David Geffen School of Medicine at UCLA Los Angeles, CA RAPHAEL J. LANDOVITZ, MD Assistant Clinical Professor Division of Infectious Diseases David Geffen School of Medicine at UCLA Los Angeles, CA JULIO MONTANER, MD Professor of Medicine University of British Columbia Director, BC Centre for Excellence in HIV/AIDS St. Paul's Hospital-Providence Health Care DAVID L. WYLES, MD Professor of Medicine Division of Infectious Diseases University of California, San Diego La Jolla, CA
At the conclusion of the course attendees should:
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
Location Center for Health Communities The California Endowment 1000 N. Alameda Street Los Angeles, CA 90012 Parking Free parking available.